Additionally, the results highlight that LA can ameliorate rosacea-like dermatitis through dual inhibition of KLK5 and TLR4/NF-κB signaling, while correcting metabolic disturbances, especially in phenylalanine metabolism. The gene discussed is NFKB1; the disease is dermatitis.